BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 23062917)

  • 1. Eccrine squamous syringometaplasia associated with vemurafenib therapy.
    Story SG; Beschloss JK; Dolan CK; Thomas BC
    J Am Acad Dermatol; 2012 Nov; 67(5):e208-10. PubMed ID: 23062917
    [No Abstract]   [Full Text] [Related]  

  • 2. Vemurafenib-induced eccrine squamous syringometaplasia.
    Lescoat A; Droitcourt C; Stock N; Le Gall F; Dupuy A
    Dermatology; 2013; 226(4):362-4. PubMed ID: 23860306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eccrine squamous syringometaplasia in sites of radiation recall secondary to vemurafenib therapy for BRAF-mutated carcinoma.
    Moioli EK; Ligtenberg KG; Kenkare S; Shea CR; Soltani K
    J Dermatol; 2016 Oct; 43(10):1233-1234. PubMed ID: 27094584
    [No Abstract]   [Full Text] [Related]  

  • 4. Vemurafenib-induced granuloma annulare.
    Lee SB; Weide B; Ugurel S; Mössner R; Enk A; Hassel JC
    J Dtsch Dermatol Ges; 2016 Mar; 14(3):305-8. PubMed ID: 26972200
    [No Abstract]   [Full Text] [Related]  

  • 5. Eccrine squamous syringometaplasia of underlying syringoma associated with Tegafur/Gimeracil/Oteracil (TS-1).
    Kim J; Kim SH; Lee MG; Chung KY; Kim DS
    Acta Derm Venereol; 2015 Nov; 95(8):999-1000. PubMed ID: 25766447
    [No Abstract]   [Full Text] [Related]  

  • 6. Eccrine squamous syringometaplasia secondary to pegylated liposomal doxorubicin.
    Garcia-Navarro X; Puig L; Fernández-Figueras MT; Alomar A
    Arch Dermatol; 2008 Oct; 144(10):1402-3. PubMed ID: 18936417
    [No Abstract]   [Full Text] [Related]  

  • 7. Targeting the adnexal epithelium: an unusual case of syringometaplasia in a patient on vemurafenib.
    Yu J; Ravikumar S; Plaza JA; Troy JL; Schieke SM
    Am J Dermatopathol; 2015 May; 37(5):e57-60. PubMed ID: 25839889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vemurafenib sensitivity skin reaction after ipilimumab.
    Harding JJ; Pulitzer M; Chapman PB
    N Engl J Med; 2012 Mar; 366(9):866-8. PubMed ID: 22375995
    [No Abstract]   [Full Text] [Related]  

  • 9. Eccrine squamous syringometaplasia associated with sunitinib therapy.
    Sheen YS; Huang CL; Chu CY
    J Eur Acad Dermatol Venereol; 2007 Sep; 21(8):1136-7. PubMed ID: 17714156
    [No Abstract]   [Full Text] [Related]  

  • 10. Acne inversa-like skin lesions as a potential adverse event during vemurafenib therapy.
    Thiem A; Mergler R; Kneitz H; Weyandt G; Goebeler M; Gesierich A
    J Dtsch Dermatol Ges; 2016 Apr; 14(4):427-8. PubMed ID: 27027759
    [No Abstract]   [Full Text] [Related]  

  • 11. Eccrine squamous syringometaplasia mimicking a herpetic infection.
    Alonso V; Ramón D; Monteagudo C; Llombart B; Martín JM; García L; Jordá E
    Int J Dermatol; 2006 Jun; 45(6):762-3. PubMed ID: 16796646
    [No Abstract]   [Full Text] [Related]  

  • 12. Imatinib-induced eccrine squamous syringometaplasia.
    Van de Voorde K; De Raeve H; Van Regenmortel N; Lambert J
    J Am Acad Dermatol; 2006 Aug; 55(2 Suppl):S58-9. PubMed ID: 16843129
    [No Abstract]   [Full Text] [Related]  

  • 13. Vemurafenib-induced panniculitis.
    Villani AP; Zaharia D; Dalle S; Depaepe L; Balme B; Thomas L
    Eur J Dermatol; 2013 Apr; 23(2):258-60. PubMed ID: 23567624
    [No Abstract]   [Full Text] [Related]  

  • 14. Erythema nodosum in a patient undergoing vemurafenib therapy for metastatic melanoma.
    Degen A; Völker B; Kapp A; Gutzmer R
    Eur J Dermatol; 2013; 23(1):118. PubMed ID: 23419281
    [No Abstract]   [Full Text] [Related]  

  • 15. Vemurafenib-induced interface dermatitis manifesting as radiation-recall and a keratosis pilaris-like eruption.
    Braunstein I; Gangadhar TC; Elenitsas R; Chu EY
    J Cutan Pathol; 2014 Jun; 41(6):539-43. PubMed ID: 24517243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxic erythema with eccrine squamous syringometaplasia induced by nanoparticle albumin-bound paclitaxel.
    Fujii M; Takahashi I; Honma M; Ishida-Yamamoto A
    J Dermatol; 2015 Nov; 42(11):1134-5. PubMed ID: 26299585
    [No Abstract]   [Full Text] [Related]  

  • 17. Histopathological features of cutaneous drug reactions to vemurafenib: a report of two cases.
    Dabner M; Harvey NT; Soma A; Wood BA
    Pathology; 2012 Dec; 44(7):661-4. PubMed ID: 23172086
    [No Abstract]   [Full Text] [Related]  

  • 18. Vincristine-induced eccrine squamous syringometaplasia.
    Thomas LM; Mohr M; Smith M; Boyd A
    Pediatr Dermatol; 2008; 25(6):623-5. PubMed ID: 19067868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Eccrine squamous syringometaplasia and cytomegalovirus infection].
    Baysse L; Boralevi F; Lepreux S; Boyer A; Morel C; Léauté-Labrèze C; Taïeb A
    Rev Med Interne; 2003 Jun; 24(6):394-8. PubMed ID: 12814829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple white cysts on face and trunk of a melanoma patient treated with vemurafenib.
    Gebhardt C; Staub J; Schmieder A; Goerdt S; Utikal J
    Acta Derm Venereol; 2015 Jan; 95(1):96-7. PubMed ID: 24710689
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.